Apogee Therapeutics Inc. Common Stock (APGE)

Stock · NASDAQ · Health Care

$134.97as of 8/28/2026

Price chart

Insider transactionsShow all transaction typesRevenue Growth

No technical signal is currently active for this symbol.

Support level

$133.88

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Chosen by industry and closest market cap.

APGE
Apogee Therapeutics Inc. Common Stock
$134.97
▲ 0.01%
Market cap $10.14BP/E —
HALO
Halozyme Therapeutics Inc. Common Stock
$105.33
▼ 1.49%
Market cap $10.17BP/E 27.63
$61.23$109.66
KYMR
Kymera Therapeutics Inc. Common Stock
$118.08
▼ 1.79%
Market cap $8.75BP/E —
$39.84$130.05
QGEN
Qiagen N.V. Common Shares
$43.12
▼ 1.43%
Market cap $8.60BP/E 22.14
$32.53$57.82
TWST
Twist Bioscience Corporation Common Stock
$141.16
▼ 7.80%
Market cap $6.84BP/E —
CRSP
CRISPR Therapeutics AG Common Shares
$57.69
▼ 2.84%
Market cap $4.99BP/E —
$44.12$78.48
NBIX
Neurocrine Biosciences Inc. Common Stock
$153.98
▼ 1.24%
Market cap $16.25BP/E 22.33
$122.14$186.12

Symbol	Market cap	P/E ratio	Price	1D	52-week range
APGE Apogee Therapeutics Inc. Common Stock	$10.14B	—	$134.97	▲ 0.01%
HALO Halozyme Therapeutics Inc. Common Stock	$10.17B	27.63	$105.33	▼ 1.49%	$61.23$109.66
KYMR Kymera Therapeutics Inc. Common Stock	$8.75B	—	$118.08	▼ 1.79%	$39.84$130.05
QGEN Qiagen N.V. Common Shares	$8.60B	22.14	$43.12	▼ 1.43%	$32.53$57.82
TWST Twist Bioscience Corporation Common Stock	$6.84B	—	$141.16	▼ 7.80%
CRSP CRISPR Therapeutics AG Common Shares	$4.99B	—	$57.69	▼ 2.84%	$44.12$78.48
NBIX Neurocrine Biosciences Inc. Common Stock	$16.25B	22.33	$153.98	▼ 1.24%	$122.14$186.12

P/E shows — for peers not currently carrying a live signal of their own.

March 31, 2026

Top holders this quarter

See the full, filterable feed with live charts on the MarketWall dashboard.